GCKR and metabolic dysfunction-associated steatotic liver disease: The GCKR rs780094 polymorphism is significantly associated with CT- and histologically proven hepatic steatosis in GWAS (OR = 1.45, p = 2.59x10−8) (Speliotes et al., 2011) and in meta-analysis of five studies (2,091 NAFLD cases and 3,003 controls) (OR: 1.25, 95% CI 1.14–1.36, p < 0.00001, I2 = 0%) (Zain et al., 2015).